Katten Represents Nuveen's Special Committee in Proposed $6.3 Billion Acquisition by Investor Group

CHICAGO - The law firm of Katten Muchin Rosenman LLP is pleased to have served as legal counsel to a Special Committee to the Board of Directors of Nuveen Investments Inc. (NYSE:JNC), in connection with the evaluation and negotiation of a buyout offer from an investor group led by Madison Dearborn Partners LLC. Nuveen, a leading provider of diversified investment services to institutional and high-net-worth investors, is the largest U.S. manager of closed-end funds. The offer to acquire Nuveen is valued at $6.3 billion, including existing debt of $550 million, and has been reported to be one of the largest buyouts of an asset manager.

Nuveen Investments stockholders will receive $65.00 in cash for each share of Nuveen common stock they own, representing a premium of 20 percent over the closing price of Nuveen shares on June 19, 2007, and a 26 percent premium to the 90-day average closing price of $51.56. The offer, announced June 20, also represents a 16 percent premium to Nuveen’s all-time, intra-day high of $56.20, which it reached on January 11, 2007.

Katten partners Herbert S. Wander, Jeffrey R. Patt and Michael J. Diver served as counsel to Nuveen’s Special Committee on the deal. All are based in the Firm’s Chicago office.

Katten’s sophisticated Mergers and Acquisitions and Corporate Governance Practices are responsive to their clients and their objectives, working efficiently, cost-effectively, and with a dedication to excellent client service. The Practices’ attorneys represent public and private clients in a broad range of domestic and international acquisitions, sales, divestitures, leveraged buyouts, management buyouts, going private transactions and joint ventures. The Mergers and Acquisitions Practice handles billions of dollars in business combinations each year, ranging from small, privately negotiated transactions to mergers of large public companies. Representation of private equity firms and private equity-backed portfolio companies also comprises a significant portion of the Practice.